OnKure Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
OnKure Therapeutics, Inc. has filed 399 SEC EDGAR filings since 08 Jan 2018

SEC filing history

Showing 151-175 of 399 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-92480

SC 13G/A filing

Filing date
16 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G

Filing date
11 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G filing

Filing date
11 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G

Filing date
11 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G filing

Filing date
11 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G

Filing date
10 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92480

SC 13D/A

Filing date
10 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
09 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92480

SC 13G

Filing date
09 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92480

SC 13G/A filing

Filing date
09 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Oct 2024
Reporting date
07 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92480

NEW ENTERPRISE ASSOCIATES 15, L.P. / ONKURE THERAPEUTICS, INC. -- SCHEDULE 13D/A

Filing date
08 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Oct 2024
Reporting date
04 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .